Orion Oyj (ORNBV.HE)

ORNBV.HE on Helsinki Stock Exchange

11:29am EST
Change (% chg)

€-0.34 (-1.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ORNBV.HE


Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical... (more)


Beta: 0.57
Market Cap(Mil.): €4,151.13
Shares Outstanding(Mil.): 141.26
Dividend: 1.25
Yield (%): 4.23


  ORNBV.HE Industry Sector
P/E (TTM): 18.39 39.97 40.64
EPS (TTM): 1.61 -- --
ROI: 29.59 18.85 18.12
ROE: 45.54 19.60 18.97
Search Stocks

Finland's Orion Q3 operating profit down 4 pct y/y

HELSINKI, Oct 21 - Finnish drug maker Orion reported a third-quarter operating profit down 4 percent from a year earlier reflecting increased competition from generic drug makers.

21 Oct 2014

BRIEF-Orion announces Precedex settlement deal

Sept 22 - Orion Oyj : * Orion announces amended settlement agreement over the proprietary drug

22 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks